STAGE IVA LIP AND ORAL CAVITY CANCER AJCC V8
Clinical trials for STAGE IVA LIP AND ORAL CAVITY CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE IVA LIP AND ORAL CAVITY CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE IVA LIP AND ORAL CAVITY CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo aims to fight tough head and neck cancers
Disease control OngoingThis study is testing whether a combination of an immunotherapy drug (cemiplimab) and two low-dose chemotherapy drugs works better for treating head and neck cancer that has returned or spread. The goal is to see if this combination helps shrink tumors and control the disease for…
Matched conditions: STAGE IVA LIP AND ORAL CAVITY CANCER AJCC V8
Phase: PHASE2 • Sponsor: Marcelo Bonomi • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
New hope for patients who Can't take standard chemo
Disease control OngoingThis early-stage trial is testing a new drug called peposertib combined with radiation therapy for patients with advanced head and neck cancer who cannot take the standard chemotherapy drug cisplatin. The main goals are to find the safest and most effective dose of peposertib and…
Matched conditions: STAGE IVA LIP AND ORAL CAVITY CANCER AJCC V8
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC